Results 31 to 40 of about 45,992 (237)
PLoS ONE, 2013 BackgroundCoronary restenosis after percutaneous coronary intervention (PCI) still remains a significant limitation of the procedure. The causative mechanisms of restenosis have not yet been fully identified.
Jeffrey J W Verschuren +9 more
doaj +1 more source
Introductory editorial: drug-eluting stents or drug-eluting grafts? Insights from proteomic analysis [PDF]
, 2017 No abstract ...
Al-Attar, Nawwar +5 more
core +1 more source
Macromolecular approaches to prevent thrombosis and intimal hyperplasia following percutaneous coronary intervention. [PDF]
, 2014 Cardiovascular disease remains one of the largest contributors to death worldwide. Improvements in cardiovascular technology leading to the current generation of drug-eluting stents, bioresorbable stents, and drug-eluting balloons, coupled with advances ...
Panitch, Alyssa, Scott, Rebecca A
core +2 more sources
Periodontitis Is Associated With Risk of Conventional Stent Restenosis: Pilot Case-Control Study
Frontiers in Dental Medicine, 2021 Objectives: Percutaneous coronary angioplasty with stent implantation has been established as the main form of treatment of atherosclerosis. However, 16 to 44% of patients may evolve with stent restenosis.
Raphael Osugue +6 more
doaj +1 more source
Genetic variants of the promoter of the heme oxygenase-1 gene and their influence on cardiovascular disease (The Ludwigshafen risk and cardiovascular health study) [PDF]
, 2009 Background Heme oxygenase-1 is an inducible cytoprotective enzyme which handles oxidative stress by generating anti-oxidant bilirubin and vasodilating carbon monoxide.
Lüblinghoff, Nicola +7 more
core +2 more sources
Future of smart cardiovascular implants [PDF]
, 2018 Cardiovascular disease remains the leading cause of death in Western society. Recent technological advances have opened the opportunity of developing new and innovative smart stent devices that have advanced electrical properties that can improve ...
Bussooa, Anubhav +2 more
core +1 more source
Restenosis after directional coronary atherectomy
Journal of the American College of Cardiology, 1992 This study evaluates the incidence of restenosis after successful directional coronary atherectomy and identifies risk factors for restenosis.Directional coronary atherectomy has been shown to be a safe and effective treatment of obstructive coronary artery disease; however, information regarding restenosis is limited.Between October 1986 and December ...
Hinohara, Tomoaki +8 more
openaire +2 more sources
Arquivos Brasileiros de Cardiologia, 2001 OBJECTIVE: To compare circulating plasma levels of immunoinflammatory markers in patients with known de novo coronary artery disease and patients with postangioplasty restenosis.
Alexandre Schaan de Quadros +6 more
doaj +1 more source
Computational Modeling Meets 3D Bioprinting: Emerging Synergies in Cardiovascular Disease Modeling
Advanced Healthcare Materials, EarlyView.Emerging advances in three‐dimensional bioprinting and computational modeling are reshaping cardiovascular (CV) research by enabling more realistic, patient‐specific tissue platforms. This review surveys cutting‐edge approaches that merge biomimetic CV constructs with computational simulations to overcome the limitations of traditional models, improve ...
Tanmay Mukherjee +7 more
wiley +1 more source
Prevention of Coronary Restenosis [PDF]
Circulation, 2000 Restenosis, the time-limited renarrowing of the lumen of a coronary artery, affects 20% to 40% of patients in the months after an initially successful intervention.1 2 As such, it represents the extreme form of the healing response that produces a normally distributed amount of late loss in lumen diameter at all interventional sites.3 To some extent ...
Richard E. Kuntz, Donald S. Baim
openaire +1 more source